Dec 3, 2025 06:40AM Leerink Partners Downgrades Aurinia Pharmaceuticals (AUPH) to Market Perform

Nov 7, 2025 02:50AM Jefferies Upgrades Aurinia Pharmaceuticals (AUPH) to Buy

Nov 4, 2025 04:43PM RBC Capital Downgrades Aurinia Pharmaceuticals (AUPH) to Sector Perform

Nov 4, 2025 06:01AM Aurinia Pharmaceuticals (AUPH) Tops Q3 EPS by 7c ; Offers Guidance

Oct 15, 2025 06:01AM Aurinia to present LUPKYNIS data at medical conferences

Sep 30, 2025 05:01AM Aurinia defends LUPKYNIS after FDA official retracts LinkedIn post

Sep 30, 2025 02:37AM Jefferies Reiterates Hold Rating on Aurinia Pharmaceuticals (AUPH)

Aug 4, 2025 05:28AM Aurinia Pharmaceuticals (AUPH) call put ratio 62 calls to 1 put with a focus on August and September calls

Jul 31, 2025 06:03AM Aurinia Pharmaceuticals (AUPH) Tops Q2 EPS by 2c ; Offers Guidance

Jul 30, 2025 06:34AM H.C. Wainwright Assumes Aurinia Pharmaceuticals (AUPH) at Buy

Jun 30, 2025 01:10PM Leerink Partners Reiterates Outperform Rating on Aurinia Pharmaceuticals (AUPH)

Jun 30, 2025 01:09PM TD Cowen Reiterates Buy Rating on Aurinia Pharmaceuticals (AUPH)

Jun 30, 2025 06:01AM Aurinia Pharmaceuticals (AUPH) Announces Positive Results from Phase 1 Study of Aritinercept (AUR200)

May 12, 2025 08:21AM Leerink Partners Reiterates Outperform Rating on Aurinia Pharmaceuticals (AUPH)

May 12, 2025 06:08AM Aurinia Pharmaceuticals (AUPH) Tops Q1 EPS by 5c, provides guidance

Feb 27, 2025 06:01AM Aurinia Pharmaceuticals (AUPH) Misses Q4 EPS by 2c, provides guidance

Nov 11, 2024 06:20AM Aurinia Pharmaceuticals (AUPH) PT Raised to $9 at RBC Capital

Nov 7, 2024 02:04PM Aurinia Pharmaceuticals (AUPH) 2600 contracts of January 12 calls trade as share price up 13%

Nov 7, 2024 09:08AM Aurinia Pharmaceuticals (AUPH) Tops Q3 EPS by 8c

Nov 7, 2024 06:10AM Aurinia Pharmaceuticals (AUPH) Announces Board Changes

Nov 7, 2024 06:02AM Aurinia Pharmaceuticals (AUPH) Tops Q3 EPS by 8c ; Offers Guidance

Oct 11, 2024 06:01AM Aurinia Pharmaceuticals (AUPH) Presents New Data Highlighting Real-World Utilization and Value of LUPKYNIS in Treating Lupus Nephritis

Sep 24, 2024 08:10AM Aurinia Pharmaceuticals (AUPH) Japan Approval of LUPKYNIS to Treat Lupus Nephritis

Sep 12, 2024 04:05PM Aurinia Pharmaceuticals (AUPH) Announces Board Restructuring

Sep 6, 2024 06:53AM H.C. Wainwright Reiterates Buy Rating on Aurinia Pharmaceuticals (AUPH)

Sep 5, 2024 07:22AM Aurinia Pharmaceuticals (AUPH) Announces First Participant Dosed in AUR200 Single Ascending Dose Trial

Aug 13, 2024 08:00AM Aurinia Pharmaceuticals (AUPH) Shareholder Calls for CEO Peter Greenleaf, Dr. Brinda Balakrishnan, and Dr. Robert Foster to Resign from the Board

Aug 1, 2024 06:04AM Aurinia Pharmaceuticals (AUPH) Reports In-Line Q2 EPS, narrows guidance